Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19.

Frise MC, Gates REV, Curry NS, Danbury CM

Open source

DOI
10.1055/s-0040-1721501
Published
2020 Oct
Container
TH open : companion journal to thrombosis and haemostasis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/s-0040-1721501,
  title = {Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19.},
  author = {Frise MC and Gates REV and Curry NS and Danbury CM},
  year = {2020},
  journal = {TH open : companion journal to thrombosis and haemostasis},
  doi = {10.1055/s-0040-1721501},
  url = {https://doi.org/10.1055/s-0040-1721501}
}

RIS

TY  - JOUR
TI  - Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19.
AU  - Frise MC
AU  - Gates REV
AU  - Curry NS
AU  - Danbury CM
PY  - 2020
JO  - TH open : companion journal to thrombosis and haemostasis
DO  - 10.1055/s-0040-1721501
UR  - https://doi.org/10.1055/s-0040-1721501
ER  - 

APA

MC, F., REV, G., NS, C., & CM, D. (2020). Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19.. TH open : companion journal to thrombosis and haemostasis. https://doi.org/10.1055/s-0040-1721501

Source records